The Receptor CMRF35-Like Molecule-1 (CLM-1) Enhances the Production of LPS-Induced Pro-Inflammatory Mediators during Microglial Activation

• Aroa Ejarque-Ortiz ,

  * E-mail: aroa.ejarque@vhir.org (AEO); joan.sayos@vhir.org (JS)

  Affiliations Immunobiology Group, CIBBIM-Nanomedicine Program, Hospital Universitari Vall d’Hebrón, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBBER-BBN), Instituto de Salud Carlos III, Barcelona, Spain

  ⨯
• Carme Solà,

  Affiliation Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas (CSIC), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

  ⨯
• Águeda Martínez-Barriocanal,

  Affiliations Immunobiology Group, CIBBIM-Nanomedicine Program, Hospital Universitari Vall d’Hebrón, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBBER-BBN), Instituto de Salud Carlos III, Barcelona, Spain

  ⨯
• Simó Schwartz Jr,

  Affiliations Drug Delivery and Targeting Group, CIBBIM-Nanomedicine Program, Hospital Universitari Vall d’Hebrón, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBBER-BBN), Instituto de Salud Carlos III, Barcelona, Spain

  ⨯
• Margarita Martín,

  Affiliation Biochemistry Unit, Faculty of Medicine, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain

  ⨯
• Hugo Peluffo,

  Affiliations Neurodegeneration Laboratory, Institut Pasteur de Montevideo, Montevideo, Uruguay, Department of Histology and Embryology, Faculty of Medicine, UDELAR, Montevideo, Uruguay

  ⨯
• Joan Sayós

  * E-mail: aroa.ejarque@vhir.org (AEO); joan.sayos@vhir.org (JS)

  Affiliations Immunobiology Group, CIBBIM-Nanomedicine Program, Hospital Universitari Vall d’Hebrón, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBBER-BBN), Instituto de Salud Carlos III, Barcelona, Spain

  ⨯